Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,451.05

36.54 (2.58%)

13:41
02/15/18
02/15
13:41
02/15/18
13:41

EPA settles with Amazon for distributions of illegal pesticides

The U.S. Environmental Protection Agency announced an agreement with Amazon Services LLC to protect the public from the hazards posed by unregistered and misbranded pesticide products. The agreement settles allegations that Amazon committed nearly four thousand violations of the "Federal Insecticide, Fungicide and Rodenticide Act" - dating back to 2013 - for selling and distributing imported pesticide products that were not licensed for sale in the United States. Under the terms of the agreement, Amazon will develop an online training course on pesticide regulations and policies that EPA believes will significantly reduce the number of illegal pesticides available through the online marketplace. The training will be available to the public and online marketers in English, Spanish and Chinese. Successful completion of the training will be mandatory for all entities planning to sell pesticides on Amazon.com. Amazon will also pay an administrative penalty of $1,215,700 as part of the consent agreement and final order entered into by Amazon and EPA's Region 10 office in Seattle, Washington.

  • 26

    Feb

  • 18

    Mar

AMZN Amazon.com
$1,451.05

36.54 (2.58%)

02/14/18
JEFF
02/14/18
NO CHANGE
JEFF
Amazon focusing on bolstering medical device distribution, says Jefferies
Yesterday's Wall Street Journal report and a recent scan of job postings still point to Amazon.com's (AMZN) focus on bolstering its medical device/supplies distribution capabilities, specifically targeting hospitals, Jefferies analyst Brian Tanquilut. These postings support a negative thesis for Cardinal Health (CAH), Owens & Minor (OMI) and Premier's (PINC) medical supplies businesses, the analyst adds. Further, he sees the news as an incremental positive for AmerisourceBergen (ABC), McKesson (MCK), CVS Health (CVS) and Walgreens Boots Alliance (WBA) since it further supports the view that Amazon isn't looking to enter the prescription business near-term.
02/14/18
BARD
02/14/18
NO CHANGE
Target $9
BARD
Neutral
ChannelAdvisor outlook likely to weigh on sentiment, says Baird
Baird analyst Colin Sebastian noted ChannelAdvisor (ECOM) missed Q4 estimates and cited non-core marketplace struggles as the cause. The analyst was positive on the company's improved performance across both the eBay (EBAY) and Amazon (AMZN) channels and is a positive for growth. Sebastian considers ChannelAdvisor a "show-me" story and maintained his Neutral rating while lowering his price target to $9 from $10 on the shares.
02/15/18
SBSH
02/15/18
NO CHANGE
Target $96
SBSH
Buy
TJX concerns brings buying opportunity, says Citi
Citi analyst Paul Lejuez says sentiment has turned cautious on TJX (TJX) following the company's weak Q3 comp. The stock has underperformed most Specialty Softlines peers over the past three months and the multiple gap with Ross Stores (ROST) is now the widest it has been in 10 years, Lejuez tells investors in a research note. He believes the concerns weighing on TJX shares presents a buying opportunity. The analyst feels the company can quickly fix the fashion miss that dragged Marmaxx's comp down in Q3. He points out that the company has been winning market share along with Amazon.com (AMZN). It's the weaker players, like mall-based department stores, that are losing to Amazon, Lejuez argues. He keeps a Buy rating on TJX with a $96 price target.
02/15/18
BERN
02/15/18
NO CHANGE
BERN
Walgreens/AmerisourceBergen deal a reaction to potential Amazon disruption, says Bernstein
Bernstein analyst Lance Wilkes sees a potential Walgreens (WBA)/AmerisourceBergen (ABC) deal as being a strategic reaction to gross margin pressures and potential disruption from Amazon (AMZN). His initial view is neutral to this deal, as he does not see it as strategically attractive, given his long-term concerns on the distributor role given his expectation of Amazon disruption to retail pharmacy. Wilkes would expect near-term synergies to be more limited, given the existing relationships between the companies and Walgreens's attractive economics already being achieved through the generic consortium.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$55.40

-0.7 (-1.25%)

11:00
02/23/18
02/23
11:00
02/23/18
11:00
Options
Starbucks puts active at the opening bell Friday »

Starbucks puts active at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 21

    Mar

PSO

Pearson

$9.66

-0.08 (-0.82%)

10:50
02/23/18
02/23
10:50
02/23/18
10:50
Hot Stocks
Pearson sees FY18 adjusted ops profit GBP520M-GBP560M »

The base for 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$96.83

-0.06 (-0.06%)

10:50
02/23/18
02/23
10:50
02/23/18
10:50
Options
25K Lowes Mar - Oct 95 call spreads bought for $5.75 »

25K Lowes Mar - Oct 95…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

PSO

Pearson

$9.66

-0.08 (-0.82%)

10:48
02/23/18
02/23
10:48
02/23/18
10:48
Earnings
Pearson reports preliminary FY17 adjusted operating profit GBP576M, down 9% »

Reports preliminary FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$39.04

0.8299 (2.17%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:45
02/23/18
02/23
10:45
02/23/18
10:45
General news
Boston Fed hawk Rosengren: low real rates are likely for some time »

Boston Fed hawk…

MDT

Medtronic

$80.51

0.1 (0.12%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Conference/Events
Medtronic has a conference call hosted by JPMorgan »

JPMorgan Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 14

    Mar

  • 23

    Mar

TTMI

TTM Technologies

$15.52

-0.07 (-0.45%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Conference/Events
TTM Technologies has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

VLKAY

Volkswagen

$40.89

0.46 (1.14%)

10:41
02/23/18
02/23
10:41
02/23/18
10:41
Earnings
Volkswagen sees fiscal 2018 sales up as much as 5% »

Volkswagen said in its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$38.15

-0.2 (-0.52%)

, FOXA

21st Century Fox

$37.16

0.1 (0.27%)

10:39
02/23/18
02/23
10:39
02/23/18
10:39
Hot Stocks
Box Office Battle: 'Black Panther' expecting $120M second weekend »

Marvel and Disney's…

VIA

Viacom

$38.15

-0.2 (-0.52%)

FOXA

21st Century Fox

$37.16

0.1 (0.27%)

LGF.B

Lionsgate

$26.79

0.01 (0.04%)

VIAB

Viacom

$32.93

-0.1 (-0.30%)

CMCSA

Comcast

$38.80

-0.21 (-0.54%)

CMCSK

Comcast

LGF.A

Lionsgate

$28.02

0.05 (0.18%)

TWX

Time Warner

$94.17

-0.2 (-0.21%)

DIS

Disney

$105.53

0.29 (0.28%)

SNE

Sony

$49.64

-0.21 (-0.42%)

FOX

21st Century Fox

$36.73

0.17 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 20

    Mar

  • 23

    Apr

10:35
02/23/18
02/23
10:35
02/23/18
10:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD slid…

ATI

Allegheny Technologies

$27.04

0.41 (1.54%)

10:33
02/23/18
02/23
10:33
02/23/18
10:33
Conference/Events
Allegheny Technologies management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 01

    May

  • 02

    May

  • 03

    May

NVRO

Nevro

$81.92

2.27 (2.85%)

10:31
02/23/18
02/23
10:31
02/23/18
10:31
Recommendations
Nevro analyst commentary  »

Nevro setup favorable,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
02/23/18
02/23
10:30
02/23/18
10:30
General news
Treasury Option Action: put buying in the belly »

Treasury Option Action:…

10:27
02/23/18
02/23
10:27
02/23/18
10:27
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts provide a…

MDXG

MiMedx

$8.88

-0.17 (-1.88%)

10:25
02/23/18
02/23
10:25
02/23/18
10:25
Conference/Events
MiMedx to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 14

    Mar

10:24
02/23/18
02/23
10:24
02/23/18
10:24
General news
Averages up in early trading but off best levels »

Stock futures moved…

WRK

WestRock

$65.72

0.44 (0.67%)

10:21
02/23/18
02/23
10:21
02/23/18
10:21
Conference/Events
WestRock management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GILD

Gilead

$79.40

-1.29 (-1.60%)

, GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

10:20
02/23/18
02/23
10:20
02/23/18
10:20
Conference/Events
Leerink pharmaceuticals analysts to hold an analyst/industry conference call »

Analyst Research Team…

GILD

Gilead

$79.40

-1.29 (-1.60%)

GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 25

    Mar

  • 23

    Apr

A

Agilent

$70.76

0.08 (0.11%)

10:20
02/23/18
02/23
10:20
02/23/18
10:20
Options
$5.6M put buyer in Agilent »

$5.6M put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

VLKAY

Volkswagen

$40.89

0.46 (1.14%)

10:19
02/23/18
02/23
10:19
02/23/18
10:19
Earnings
Volkswagen reports year adjusted operating profit EUR 17B, consensus EUR 17.29B »

Reports year revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLTW

Willis Towers Watson

$156.53

-1.04 (-0.66%)

10:19
02/23/18
02/23
10:19
02/23/18
10:19
Conference/Events
Willis Towers Watson management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 16

    Apr

$NSD

NASDAQ Market Internals

10:17
02/23/18
02/23
10:17
02/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCN

Waste Connections

$70.82

0.03 (0.04%)

10:16
02/23/18
02/23
10:16
02/23/18
10:16
Conference/Events
Waste Connections management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

$NYE

NYSE Market Internals

10:16
02/23/18
02/23
10:16
02/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.